Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Projections of the costs associated with colorectal cancer care in the United States, 2000-2020.

Yabroff KR, Mariotto AB, Feuer E, Brown ML.

Health Econ. 2008 Aug;17(8):947-59.

PMID:
17910108
2.

Economic costs of diabetes in the U.S. In 2007.

American Diabetes Association.

Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Review. Erratum in: Diabetes Care. 2008 Jun;31(6):1271.

PMID:
18308683
3.

Measuring costs: administrative claims data, clinical trials, and beyond.

Etzioni R, Riley GF, Ramsey SD, Brown M.

Med Care. 2002 Jun;40(6 Suppl):III63-72. Review.

PMID:
12064760
4.

Costs of cancer care in the USA: a descriptive review.

Yabroff KR, Warren JL, Brown ML.

Nat Clin Pract Oncol. 2007 Nov;4(11):643-56. Review.

PMID:
17965642
5.

Colorectal cancer: national and international perspective on the burden of disease and public health impact.

Gellad ZF, Provenzale D.

Gastroenterology. 2010 Jun;138(6):2177-90. doi: 10.1053/j.gastro.2010.01.056. Review.

PMID:
20420954
6.

The economic burden of prostate cancer.

Roehrborn CG, Black LK.

BJU Int. 2011 Sep;108(6):806-13. doi: 10.1111/j.1464-410X.2011.10365.x. Review.

7.
8.

The increasing impact of arthritis on public health.

Elders MJ.

J Rheumatol Suppl. 2000 Oct;60:6-8. Review.

PMID:
11032095
9.

Projecting future drug expenditures--2001.

Mehl B, Santell J.

Am J Health Syst Pharm. 2001 Jan 15;58(2):125-33. Review.

PMID:
11202535
10.

Screening, prevention and socioeconomic costs associated with the treatment of colorectal cancer.

Redaelli A, Cranor CW, Okano GJ, Reese PR.

Pharmacoeconomics. 2003;21(17):1213-38. Review.

PMID:
14986736
11.

Health care costs tied to many issues.

Bove VM.

Physician Exec. 1992 Sep-Oct;18(5):23-9. Review.

PMID:
10121673
12.

Estimating the cost of epilepsy in Europe: a review with economic modeling.

Pugliatti M, Beghi E, Forsgren L, Ekman M, Sobocki P.

Epilepsia. 2007 Dec;48(12):2224-33. Review.

13.

The costs of Crohn's disease in the United States and other Western countries: a systematic review.

Yu AP, Cabanilla LA, Wu EQ, Mulani PM, Chao J.

Curr Med Res Opin. 2008 Feb;24(2):319-28. Review.

PMID:
18067689
14.

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review.

Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C.

Cancer Treat Rev. 2008 May;34(3):193-205. doi: 10.1016/j.ctrv.2007.12.001. Epub 2008 Mar 4. Review.

PMID:
18313224
15.

Economics and cost of care of stone disease.

Lotan Y.

Adv Chronic Kidney Dis. 2009 Jan;16(1):5-10. doi: 10.1053/j.ackd.2008.10.002. Review.

PMID:
19095200
16.

Value and cancer care: toward an equitable future.

Schnipper LE, Meropol NJ, Brock DW.

Clin Cancer Res. 2010 Dec 15;16(24):6004-8. doi: 10.1158/1078-0432.CCR-10-1643. Review.

17.

Economic studies in colorectal cancer: challenges in measuring and comparing costs.

Yabroff KR, Borowski L, Lipscomb J.

J Natl Cancer Inst Monogr. 2013;2013(46):62-78. doi: 10.1093/jncimonographs/lgt001. Review.

18.

Symptomatic articular cartilage degeneration: the impact in the new millennium.

Jackson DW, Simon TM, Aberman HM.

Clin Orthop Relat Res. 2001 Oct;(391 Suppl):S14-25. Review.

PMID:
11603698
19.

The burden of illness of cancer: economic cost and quality of life.

Brown ML, Lipscomb J, Snyder C.

Annu Rev Public Health. 2001;22:91-113. Review.

PMID:
11274513
20.

The costs of cancer care in the United States: implications for action.

Schuette HL, Tucker TC, Brown ML, Potosky AL, Samuel T.

Oncology (Williston Park). 1995 Nov;9(11 Suppl):19-22. Review.

Supplemental Content

Support Center